---
schema_version: "secwatch.filing_event.v1"
accession: "0001099800-26-000028"
form_type: "8-K"
ticker: "EW"
cik: "0001099800"
company_name: "Edwards Lifesciences Corp"
filed_at: "2026-05-08T23:59:59+00:00"
generated_at: "2026-05-14T19:42:23.092659+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Edwards shareholders approve 7M share increase in Long-Term Stock Program

## Summary
- Stockholders authorized 7M additional shares, raising total available to 341.5M under the amended program.
- All 9 director nominees reelected; proposal received between 428M and 474M For votes each.
- Advisory vote on named executive officer compensation passed with ~89% of votes cast.
- Ratification of PwC as independent auditor for FY2026 approved with ~89% of votes cast.
- Stock program amendment (Proposal 4) passed with 456.7M For (96% of votes cast, excluding broker non-votes).

## SEC filing metadata
- accession: 0001099800-26-000028
- form_type: 8-K
- ticker: EW
- cik: 0001099800
- company_name: Edwards Lifesciences Corp
- filed_at: 2026-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1099800/000109980026000028/0001099800-26-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1099800/000109980026000028/ew-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001099800-26-000028
- JSON: https://secwatch.observer/filing/0001099800-26-000028.json
- Plain text: https://secwatch.observer/filing/0001099800-26-000028.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.